FDA Approves Blood Test for Colon Cancer and Novel ADHD Drug

The FDA has approved SimpleScreen CRC, a blood-based screening test for colorectal cancer in adults 45 and older at average risk. This is the second blood test approved for colon cancer screening, joining Guardant Health's Shield test. The approval is based on the PREEMPT CRC study of over 48,000 adults, showing 81.1% sensitivity for detecting colorectal cancer and 90.4% specificity. The test is covered by Medicare, making it accessible to...